Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Next generation sequencing industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Product type trends
2.1.3 Application trends
2.1.4 Type trends
2.1.5 Technology trends
2.1.6 End-use trends
2.1.7 Regional trends
Chapter 3 Next Generation Sequencing Industry Insights
3.1 Industry landscape, 2018 – 2032
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing technological advancements in next generation sequencing in developed countries
3.2.1.2 Increasing research and development activities in North America and Europe
3.2.1.3 Growing use of NGS technology by pharmaceutical and biopharmaceutical companies in advanced economies
3.2.1.4 Favorable regulatory scenario in North America
3.2.2 Industry pitfalls & challenges
3.2.2.1 Dearth of skilled professionals
3.2.2.2 High cost of next generation sequencing
3.3 Growth potential analysis
3.3.1 By product type
3.3.2 By application
3.3.3 By type
3.3.4 By technology
3.3.5 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Agilent Technologies, Inc.
4.1.2 BGI, Bio-Rad Laboratories
4.1.3 F Hoffmann-La Roche
4.2 Competitive dashboard, 2022
4.3 Company matrix analysis, 2022
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 Next Generation Sequencing Market, By Product Type
5.1 Key segment trends
5.2 Instruments
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Consumables
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Services
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Next Generation Sequencing Market, By Application
6.1 Key segment trends
6.2 Research
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Clinical
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.2 Cardiovascular
6.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.3 Reproductive health
6.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.4 Cancer
6.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.5 Infectious diseases
6.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.6 Others
6.3.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Others
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Next Generation Sequencing Market, By Type
7.1 Key segment trends
7.2 Whole genome sequencing (WGS)
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Exome sequencing
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Targeted sequencing
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Others
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Next Generation Sequencing Market, By Technology
8.1 Key segment trends
8.2 Sequencing by synthesis
8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Ion semiconductor sequencing
8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.4 Other
8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 Next Generation Sequencing Market, By End-use
9.1 Key segment trends
9.2 Academic institutes & research centers
9.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.3 Hospitals & clinics
9.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.4 Pharmaceutical & biotechnology companies
9.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.5 Others
9.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 10 Next Generation Sequencing Market Market, By Region
10.1 Key regional trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Poland
10.3.7 Switzerland
10.3.8 Sweden
10.4 Asia Pacific
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 Australia
10.4.5 South Korea
10.4.6 Thailand
10.4.7 Indonesia
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Columbia
10.5.5 Chile
10.5.6 Peru
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 South Africa
10.6.3 UAE
10.6.4 Israel
Chapter 11 Company Profiles
11.1 10X Genomics
11.2 Agilent Technologies, Inc.
11.3 BGI
11.4 Bio-Rad Laboratories
11.5 F Hoffmann-La Roche
11.6 GenapSys Inc.
11.7 Illumina, Inc.
11.8 NanoString Technologies, Inc.
11.9 Oxford Nanopore Technologies
11.10 Pacific Biosciences of California, Inc.
11.11 PerkinElmer Inc.
11.12 Qiagen
11.13 Thermo Fisher Scientific
